Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedixTSE:331A -0.61%20 5-Year Yield-on-Cost % is 3.66 as of Aug. 25, 2026, which is 1% below its 10-year median of 3.70. GuruFocus rates TSE:331A with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 385 Media - Diversified companies, Medix ranks better than 50.13% on this metric.
Medix's yield on cost for the quarter that ended in Mar. 2026 was 3.66.
The historical rank and industry rank for Medix's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:331A'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.56 Med: 3.7 Max: 3.85
Current: 3.66
During the past 4 years, Medix's highest Yield on Cost was 3.85. The lowest was 3.56. And the median was 3.70.
TSE:331A's 5-Year Yield-on-Cost % is ranked better than 50.13% of 385
companies
in the Media - Diversified industry
Industry Median: 3.66
vs TSE:331A: 3.66
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Medix 5-Year Yield-on-Cost % Related Terms
TSE:331A vs APP, OMC, TTD: 5-Year Yield-on-Cost % Comparison
For the Advertising Agencies subindustry, Medix's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medix 5-Year Yield-on-Cost % vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Medix's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Medix's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Medix is calculated as
Medix (TSE:331A) has a 5-Year Yield-on-Cost % of 3.66 as of Aug. 25, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medix and its competitors. This is near median its historical median of 3.70. Over the past decade, Medix's 5-Year Yield-on-Cost % has ranged from 3.56 to 3.85. According to the industry distribution chart, Medix ranks #192 out of 385 companies in the Media - Diversified industry, placing it in the top 49.9%.
Is Medix's 5-Year Yield-on-Cost % too high?
Medix's current 5-Year Yield-on-Cost % of 3.66 is near median its 10-year median of 3.70. Over the past 10 years, this metric has ranged from a low of 3.56 to a high of 3.85. The Media - Diversified industry median 5-Year Yield-on-Cost % is 3.66. Medix's value of 3.66 is 0% at this industry median. Based on the distribution chart, Medix ranks #192 out of 385 companies in the Media - Diversified industry, which is above the industry midpoint. Overall, Medix has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Medix's 5-Year Yield-on-Cost % compare to APP and OMC?
According to the Media - Diversified industry distribution chart, Medix ranks #192 out of 385 companies for 5-Year Yield-on-Cost %. This puts Medix in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 3.66. Medix's value of 3.66 is 0% at this benchmark. Historically, Medix's own 5-Year Yield-on-Cost % has ranged from 3.56 to 3.85 over the past decade. While the company's 10-year median is 3.70 vs. the industry median of 3.66, Medix has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Media - Diversified company?
The median 5-Year Yield-on-Cost % among Media - Diversified companies is 3.66, based on 385 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medix's current 5-Year Yield-on-Cost % of 3.66 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medix and its competitors. For the Media - Diversified industry, the median 5-Year Yield-on-Cost % is 3.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medix's current 5-Year Yield-on-Cost % is 3.66, which is near median its own 10-year median of 3.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medix stock overvalued right now?
Medix (TSE:331A) has a current 5-Year Yield-on-Cost % of 3.66. The current 5-Year Yield-on-Cost % is 3.66, which is near median its 10-year median of 3.70 and 0% at the Media - Diversified industry median of 3.66. Medix's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medix (TSE:331A), the current 5-Year Yield-on-Cost % is 3.66 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medix Inc is an internet advertising agency that places the utmost importance on understanding its clients' business models deeply and helping them solve problems over the medium to long term. It is engaged in Digital marketing services including creative design and production, data parsing and analysis, and Internet advertising services. The company provides services in the digital marketing field to clients in various lines and industries.
20GF Score
Get the complete analysis for TSE:331A
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:331A has been successfully added to your 
